An Annual Prostate Cancer Screening Test

Prostate Cancer often has no symptoms until the disease is advanced, and screening may help detect cancer early, when the chances of treatment success are high. Trucheck™ - Prostate is a revolutionary test, based on a simple blood draw, for early detection of Prostate Cancer in asymptomatic individuals.

See Our Latest Press Release

Slider Image
Slider Image

An Annual Prostate Cancer Screening Test

Prostate Cancer often has no symptoms until the disease is advanced, and screening may help detect cancer early, when the chances of treatment success are high. Trucheck™ - Prostate is a revolutionary test, based on a simple blood draw, for early detection of Prostate Cancer in asymptomatic individuals.

See Our Latest Press Release

Advantages of Trucheck™?

Slider Image

Being a non-invasive blood-based test, Trucheck™ can minimize the need to visit a healthcare centre – since the blood sample can also be collected from the privacy and comfort of your home.

Advantages to the individuals:

  1. Wait times for appointments are reduced
  2. Minimized risk of COVID exposure
  3. May be assimilated into annual health check-up
  4. No risk of radiation or those associated with invasive procedures

Advantages to the system:

  1. Reduces risk of COVID transmission and exposure of staff
  2. Reductions in avoidable / non-critical appointments
  3. Minimizes procedures that may be retrospectively deemed unnecessary
  4. Supports decision making in conjunction with existing tests / methods
The Advantage of Early Detection
Slider Image Slider Image

Cancer Facts You Should Know

Prostate Cancer affects more than 1.5 million men annually. More than 375,000 men die of Prostate Cancer each year.

Studies have shown that early detection of Prostate Cancer drastically improves survival rates. Trucheck™ - Prostate is a non-invasive diagnostic blood test that can enable early detection of Prostate Cancer in asymptomatic individuals.

Trucheck™ - Prostate is totally non-invasive, radiation free and can be availed from the comfort of your office or home. Trucheck™ - Prostate is intended to be performed annually as a routine test.


Why should I consider Trucheck™?

Circulating Tumor Cells (CTCs) and their clusters are present in the blood of almost all cancer patients and are undetectable even in seemingly healthy individuals.
Trucheck™ technology to detect and characterise CTCs has been proven through extensive clinical validations involving more than 40,000 participants. The test is a paradigm shift in cancer screening, as it does not involve radiation or invasive procedures. The test is performed at our world-class laboratory, which meets and exceeds all national and international standards.
Slider Image

Illustrative Images of CTCs


Prostate
CK7, CK20, PSMA, AMACR, P63
Slider Image

Trucheck™ - Prostate is Accurate


The Development of Trucheck™ - Prostate includes extensive Analytical and Clinical validation studies to establish its Accuracy and Reliability.

Trucheck™ - Prostate has overall accuracy > 99%.

For Patients

Ask Your Doctor


Our patient's downloadable content has all the information you and your doctor need to discuss Trucheck™ testing.